scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1035887298 |
P356 | DOI | 10.1111/J.1523-1755.2004.00812.X |
P698 | PubMed publication ID | 15327420 |
P50 | author | Yoshiharu Tsubakihara | Q43610815 |
P2093 | author name string | Enyu Imai | |
Tatsuya Shoji | |||
Masamitsu Fujii | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nephrology | Q177635 |
hemodialysis patient | Q126109077 | ||
patient | Q181600 | ||
hemodialysis | Q391744 | ||
P304 | page(s) | 1212-1220 | |
P577 | publication date | 2004-09-01 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients | |
P478 | volume | 66 |
Q38606158 | A Clinical Prediction Score to Guide Referral of Elderly Dialysis Patients for Kidney Transplant Evaluation |
Q47223238 | A Simplified Approach to Extravascular Lung Water Assessment Using Point-of-Care Ultrasound in Patients with End-Stage Chronic Renal Failure Undergoing Hemodialysis |
Q39404701 | A brief review of intradialytic hypotension with a focus on survival |
Q37211311 | A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival |
Q34420471 | A randomized controlled trial of long term effect of BCM guided fluid management in MHD patients (BOCOMO study): rationales and study design |
Q41364143 | A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension |
Q36442980 | A systematic review of the clinical effects of reducing dialysate fluid temperature. |
Q44397458 | Absolute Blood Volume in Hemodialysis Patients: Why Is It Relevant, and How to Measure It |
Q47343980 | Absolute interdialytic weight gain is more important than percent weight gain for intradialytic hypotension in heavy patients |
Q44027840 | Acetate-Free Biofiltration Reduces Intradialytic Hypotension: A European Multicenter Randomized Controlled Trial |
Q46881110 | Adenosine A1 receptor antagonist improves intradialytic hypotension |
Q42336266 | Advances in the cardiovascular assessment of patients with chronic kidney disease |
Q50988765 | Antihypertensive Medications in End-Stage Renal Disease |
Q58912060 | Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients |
Q33974561 | Assessment and management of hypertension in patients on dialysis |
Q36864059 | Association of Intradialytic Blood Pressure Variability With Increased All-Cause and Cardiovascular Mortality in Patients Treated With Long-term Hemodialysis |
Q36663612 | Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline |
Q37399705 | Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study |
Q35124248 | Association of mortality risk with various definitions of intradialytic hypotension |
Q35127719 | Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension |
Q64242677 | Bioimpedance Spectroscopy-Guided Ultrafiltration Normalizes Hydration and Reduces Intradialytic Adverse Events in Hemodialysis Patients |
Q37275998 | Bioimpedance spectroscopy method to determine hypervolemia in maintenance hemodialysis patients |
Q40293558 | Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality |
Q90379195 | Blood Pressure Changes among Patients Undergoing Hemodialysis in Yenagoa, Nigeria |
Q38827154 | Blood Pressure and Mortality in Hemodialysis Patients: A Systematic Review of an Ongoing Debate |
Q38045940 | Blood pressure and blood volume: acute and chronic considerations in hemodialysis. |
Q83400963 | Blood pressure and outcome in patients on dialysis |
Q30429482 | Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease |
Q47790800 | Blood pressure in hemodialysis: targets? |
Q37476741 | Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study |
Q100737201 | Blood pressure management in patients receiving renal replacement therapy |
Q38817577 | Blood pressure targets for hemodialysis patients: Aspirational or practical? |
Q79761776 | Body fat mass and lean mass as predictors of survival in hemodialysis patients |
Q48272139 | Can intensive hemodialysis prevent loss of functionality in the elderly ESRD patient? |
Q41918048 | Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients |
Q33776660 | Cardiovascular Autonomic Neuropathy Studied by a Laser-Doppler Blood Flowmeter in Hemodialysis Patients |
Q89964395 | Cardiovascular Mortality Can Be Predicted by Heart Rate Turbulence in Hemodialysis Patients |
Q34453236 | Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs |
Q36379651 | Cardiovascular dialysis instability and convective therapies |
Q38025185 | Cardiovascular disease in chronic kidney disease: untying the Gordian knot |
Q39096879 | Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations |
Q92103912 | Cardiovascular protection and mounting evidence for the benefits of intradialytic exercise |
Q35606726 | Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients? |
Q36366223 | Changes in physical activity and risk of all-cause mortality in patients on maintence hemodialysis: a retrospective cohort study |
Q91637360 | Characteristics of visit-to-visit blood pressure variability in hemodialysis patients |
Q55437740 | Clinical usefulness of bioimpedance analysis for assessing volume status in patients receiving maintenance dialysis. |
Q26741439 | Clinical, patient-related, and economic outcomes of home-based high-dose hemodialysis versus conventional in-center hemodialysis |
Q38766192 | Cold dialysis and its impact on renal patients' health: An evidence-based mini review |
Q91803601 | Comparison of risk of stroke in patients treated with peritoneal dialysis and hemodialysis: a systematic review and meta-analysis |
Q47809967 | Comparison of stroke volume measurements during hemodialysis using bioimpedance cardiography and echocardiography |
Q37042051 | Control of core temperature and blood pressure stability during hemodialysis. |
Q26765062 | Cooling dialysate during in-center hemodialysis: Beneficial and deleterious effects |
Q89905843 | Cramping, crashing, cannulating, and clotting: a qualitative study of patients' definitions of a "bad run" on hemodialysis |
Q57060389 | Current approaches to middle molecule removal: room for innovation |
Q91825337 | Dataset supporting blood pressure prediction for the management of chronic hemodialysis |
Q38687066 | Definitions of intradialytic hypotension |
Q27023025 | Diabetes and end-stage renal disease; a review article on new concepts |
Q94326571 | Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis |
Q37522647 | Dialysis dose and intradialytic hypotension: results from the HEMO study |
Q86127169 | Dialysis fata morgana: can we finally successfully tackle intradialytic hypotension with plasma sodium biofeedback systems? |
Q38185855 | Dialysis hypotension: a role for inadequate increase in arginine vasopressin levels? A systematic literature review and meta-analysis |
Q36002351 | Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality |
Q36358756 | Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study |
Q40363286 | Effect of fluid loading on left ventricular volume and stroke volume variability in patients with end-stage renal disease: a pilot study |
Q33413288 | Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials |
Q58721092 | Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study |
Q43812327 | Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial |
Q35812096 | Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials |
Q37514832 | Effects of hemodialysis on cardiac function |
Q47204294 | Effects of weight-based ultrafiltration rate limits on intradialytic hypotension in hemodialysis |
Q37476022 | Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial |
Q33749198 | Efficacy of hemocontrol biofeedback system in intradialytic hypotension-prone hemodialysis patients. |
Q38994788 | Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis |
Q44107637 | Evaluation of intradialytic hypotension using impedance cardiography |
Q83887513 | Evolution of volume sensitivity during hemodialysis and ultrafiltration |
Q84166949 | Excessive Fall of Blood Pressure During Maintenance Hemodialysis in Patients With Chronic Renal Failure Is Induced by Vascular Malfunction and Imbalance of Autonomic Nervous Activity |
Q57192749 | Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory function |
Q84149849 | Experiment of self blood pressure measurement at home in haemodialysis patients in a hospital unit |
Q36875577 | Exploring haemodynamics of haemodialysis using extrema points analysis model. |
Q37531432 | Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension |
Q41859773 | Feasibility of intermittent back-filtrate infusion hemodiafiltration to reduce intradialytic hypotension in patients with cardiovascular instability: a pilot study |
Q47850551 | Feeding during dialysis-risks and uncertainties |
Q43054831 | Fluid management: the challenge of defining standards of care |
Q53365078 | Frequent hemodialysis: history of the modality and assessment of outcomes |
Q45142637 | Health status detection for patients in physiological monitoring |
Q41685776 | Hemodialysis immediately after cardiac catheterization is a risk factor for intradialytic hypotension |
Q86998730 | Hemodialysis-Induced Acute Myocardial Dyssynchronous Impairment in Children |
Q57823362 | Hemodialysis-Induced Left Ventricular Dysfunction Is Associated with an Increase in Ventricular Arrhythmias |
Q37176822 | Hemodialysis-induced cardiac injury: determinants and associated outcomes |
Q40331776 | Hemodynamic Response to Hemodialysis With Ultrafiltration Rate Profiles Either Gradually Decreasing or Gradually Increasing |
Q50958453 | High Stroke Volume Variation Is an Independent Predictor for Decreased Blood Pressure During Hemodialysis |
Q47749623 | Higher Ultrafiltration Rate Is Associated with Longer Dialysis Recovery Time in Patients Undergoing Conventional Hemodialysis |
Q38196961 | Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation. |
Q39417554 | Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors |
Q55018837 | Impaired Gut Epithelial Tight Junction Expression in Hemodialysis Patients Complicated with Intradialytic Hypotension. |
Q36406147 | Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin E-bonded polysulfone membrane dialyzers |
Q38204985 | In-center nocturnal hemodialysis |
Q24234733 | Interventions for preventing intradialytic hypotension in haemodialysis patients |
Q24192974 | Interventions for preventing intradialytic hypotension in haemodialysis patients |
Q51181276 | Intra-dialytic blood oxygen saturation (SO2): association with dialysis hypotension (the SOGLIA Study). |
Q38805335 | Intra-dialytic hypotension: Identifying patients most at risk. |
Q93135239 | Intradialysis blood pressure changes among chronic kidney disease patients on maintenance haemodialysis in a tertiary hospital south - south Nigeria: a 2 year retrospective study |
Q36600079 | Intradialytic Blood Pressure Abnormalities: The Highs, The Lows and All That Lies Between |
Q92087767 | Intradialytic Hypotension: Mechanisms and Outcome |
Q98178887 | Intradialytic Symptoms and Recovery Time in Patients on Thrice-Weekly In-Center Hemodialysis: A Cross-sectional Online Survey |
Q37802271 | Intradialytic hypotension |
Q33359991 | Intradialytic hypotension and cardiac remodeling: a vicious cycle |
Q34629717 | Intradialytic hypotension and risk of cardiovascular disease |
Q35142734 | Intradialytic hypotension and vascular access thrombosis |
Q92128013 | Intradialytic hypotension is an important risk factor for critical limb ischemia in patients on hemodialysis |
Q40227437 | Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients |
Q51165588 | Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. |
Q37822893 | Intra‐dialytic hypotension and blood volume and blood temperature monitoring |
Q90211501 | Investigation of heart rate variability and heart rate turbulence in chronic hypotensive hemodialysis patients |
Q30235108 | Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. |
Q38411369 | Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? |
Q50502242 | Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis |
Q91796109 | Long-Term Peridialytic Blood Pressure Patterns in Patients Treated by Hemodialysis and Hemodiafiltration |
Q48176858 | Long-term impacts of hemodialysis on the right ventricle: Assessment via 3-dimensional speckle-tracking echocardiography. |
Q40037882 | Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. |
Q33826985 | Measures of blood pressure and cognition in dialysis patients. |
Q52372572 | Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension |
Q50119222 | Medical safety in the care of the person with end-stage kidney disease |
Q84072772 | Nephrologists should strive for optimal haemodialysis: the case of 8-hour thrice-weekly in-centre haemodialysis |
Q37590659 | Neurological complications of chronic kidney disease |
Q87319762 | Non invasive evaluation of cardiac hemodynamics in end stage renal disease (ESRD) |
Q93082891 | Non-invasive hemodynamic profiling of patients undergoing hemodialysis - a multicenter observational cohort study |
Q46149455 | Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes |
Q89452693 | Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench |
Q46186819 | Olmesartan clinical trial in Okinawan patients under OKIDS (OCTOPUS) study: design and methods |
Q95654138 | Optimizing Intraoperative Blood Pressure to Improve Outcomes in Living Donor Renal Transplantation |
Q37152510 | Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments |
Q45841964 | Peri-dialytic hypertension and hypotension: another U-shaped BP-outcome association |
Q37624058 | Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease |
Q38837987 | Pneumatic Compression, But Not Exercise, Can Avoid Intradialytic Hypotension: A Randomized Trial. |
Q43422810 | Pneumatic compression devices during hemodialysis: a randomized crossover trial |
Q90591475 | Postdialysis blood pressure is a better predictor of mortality than predialysis blood pressure in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study |
Q45967311 | Pre to post‐dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis |
Q37217608 | Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study |
Q64116263 | Predicting intradialytic hypotension using heart rate variability |
Q35692508 | Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study |
Q37189161 | Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation |
Q36839878 | Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation |
Q48595209 | Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan |
Q46372173 | Prevalence and risk factors of intra-dialytic hypotension: a 5 year retrospective report from a single Nigerian Centre |
Q50084092 | Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. |
Q38094065 | Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease |
Q33621194 | Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients |
Q36240900 | Quality of life in patients on chronic dialysis in South Africa: a comparative mixed methods study. |
Q48131228 | Quality of life of elderly patients on peritoneal dialysis versus hemodialysis: a single-center study. |
Q40073611 | RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan. |
Q47849007 | Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis |
Q34969853 | Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. |
Q40303793 | Relationship between Hypotension and Cerebral Ischemia during Hemodialysis |
Q50756404 | Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions |
Q90592491 | Role of Lung Ultrasound in Adjusting Ultrafiltration Volume in Hemodialysis Patients |
Q47105380 | Safety and Efficacy of Losartan 50 mg in Reducing Blood Pressure among Patients with Post-Dialysis Euvolemic Hypertension: A Randomized Control Trial. |
Q36662018 | Serum vasopressin response in patients with intradialytic hypotension: a pilot study |
Q47203062 | Setting the dry weight and its cardiovascular implications |
Q36637898 | Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension: A Systematic Review and Meta-Analysis |
Q35648208 | Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study). |
Q39407357 | Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension |
Q33697353 | Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it? |
Q46542338 | Symmetric dimethylarginine is an independent predictor of intradialytic hypotension. |
Q38102731 | Sympathetic Nervous System Function and Dysfunction in Chronic Hemodialysis Patients |
Q37997453 | Symptomatic Intradialytic Hypotension and Mortality: An Opinionated Review |
Q34020784 | Systolic blood pressure and mortality in patients on hemodialysis. |
Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
Q92298365 | The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis |
Q35116289 | The accuracy of a continuous volumetric balancing system in pediatric continuous renal replacement therapy |
Q37333672 | The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions |
Q92026878 | The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis |
Q38284277 | The choice of dialysate sodium is influenced by hemodialysis frequency and duration: what should it be and for what modality? |
Q91966871 | The effect of BCM guided dry weight assessment on short-term survival in Chinese hemodialysis patients : Primary results of a randomized trial - BOdy COmposition MOnitor (BOCOMO) study |
Q83923975 | The effect of metanephros transplantation on blood pressure in anephric rats with induced acute hypotension |
Q50552009 | The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotension |
Q40138047 | The impact of hemodialysis schedules on the day of the week of hospitalization for cardiovascular and infectious diseases, over a period of 20 years |
Q54502610 | The influence of blood volume-controlled ultrafiltration on hemodynamic stability and quality of life. |
Q47338354 | The influence of decreased low-molecular-weight heparin nadroparin dose on diastolic blood pressure in patients on hemodialysis |
Q43204701 | The relationship between intradialytic hypotension and vascular calcification in hemodialysis patients. |
Q38881785 | The relationship between survival rate and intradialytic blood pressure changes in maintenance hemodialysis patients |
Q36380161 | The relationship between symptoms and blood pressure during maintenance hemodialysis |
Q42938789 | Time to improve fluid management in hemodialysis: should we abandon clinical assessment and routinely use bioimpedance? |
Q39407364 | To cool, or too cool: Is reducing dialysate temperature the optimal approach to preventing intradialytic hypotension? |
Q51127757 | Treatment of post-dialytic orthostatic hypotension with an inflatable abdominal band in hemodialysis patients |
Q39201803 | Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy? |
Q41849825 | Ultrafiltration biofeedback guided by blood volume monitoring to reduce intradialytic hypotensive episodes in hemodialysis: study protocol for a randomized controlled trial. |
Q54986847 | Use of fludrocortisone for intradialytic hypotension. |
Q64069763 | Use of vasopressor for dialysis-related hypotension is a risk factor for death in hemodialysis patients: Nationwide cohort study |
Q38374824 | Vasopressin and prevention of hypotension during hemodialysis. |
Q83419927 | Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis |
Q84246182 | Vasopressin secretion by hypertonic saline infusion during hemodialysis: effect of cardiopulmonary recirculation |
Q79744882 | Vasopressin: a look at dialysis hypertension and autonomic dysfunction |
Q91522785 | We can have it all, but we just cannot have it all at once |
Q36909448 | What Is Known and Unknown About Twice-Weekly Hemodialysis |
Q43077646 | What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study |
Q46023515 | What are the Consequences of Volume Expansion in Chronic Dialysis Patients?: Intra-dialytic Hypotension in Conventional Hemodialysis: Unavoidable in Some, but Preventable in Most. |
Q38153072 | What are the causes of the ill effects of chronic hemodialysis? Balancing risks: blood pressure targets, intradialytic hypotension, and ischemic brain injury |
Q80871631 | [Does hypertension impact on the mortality of hemodialysis patients?] |
Search more.